Family Dental Care of Owasso โ€” Financial & Operational Analysis

A data-driven review of revenue performance, cost structure, and operating efficiency across FY 2025 and YTD 2026. Built for strategic decision-making, not reporting.

๐Ÿ’ฐ
Annual Revenue
$3.26M
FY 2025 Actual
๐Ÿ“Š
Income Before Doctor Sharing
26.3%
Margin โ€” FY 2025
๐Ÿ“ˆ
Final Operating Margin
21.0%
After Doctor Comp
๐Ÿฆท
Revenue / Doctor Day
$15,700
โ†‘ 31โ€“96% above avg
01

Executive Summary

FY 2025 โ€” Financial Summary
Total Revenue ~$3,260,000
Income Before Doctor Sharing (IBDS) ~$857,800
IBDS Margin 26.3%
Income From Operations (Final) ~$684,900
Final Operating Margin 21.0%
Metric note: This analysis uses Income Before Doctor Sharing as the core operating metric. Income From Operations is reported separately as the final outcome after doctor compensation.
Analytical Summary

Family Dental Care of Owasso is a high-efficiency, single-doctor dental practice generating approximately $3.26M in annual revenue. The practice demonstrates strong production density โ€” $15,700 per doctor day โ€” and a controlled overhead structure that sustains margins well above single-location dental benchmarks.

Month-to-month performance varies, reflecting the natural cadence of scheduling, case mix, and timing of expenses. The underlying operating model, however, is structurally sound: labor is well-managed, supply costs are exceptionally lean, and occupancy is below industry norms.

Core Metric
Income Before Doctor Sharing โ€” primary measure of practice-level operating performance
Final Outcome
Income From Operations โ€” reported after doctor compensation, reflects take-home profitability
02

2025 Performance

Monthly Breakdown โ€” FY 2025

Revenue, IBDS margin, and final operating margin by month. Performance tags reflect overall month quality.

Elite Strong Watch Weak
Month Revenue IBDS Margin Final Ops Margin Tag
Jan 2025 $286,768 20.6% 8.6% Watch
Feb 2025 $275,012 21.9% 21.9% Watch
Mar 2025 $305,156 30.9% 30.9% Strong
Apr 2025 $332,794 33.2% 22.0% Elite
May 2025 $214,397 Margin-pressured Margin-pressured Weak
Jun 2025 $269,628 Strong / controlled Strong / controlled Strong
Jul 2025 $359,708 31.3% Distorted by sharing Elite
Aug 2025 $248,656 Watch Watch Watch
Sep 2025 $230,993 Inefficient Inefficient Weak
Oct 2025 $243,742 Efficient Efficient Strong
Nov 2025 $238,601 Watch Watch Watch
Dec 2025 $259,452 24.5% 24.5% Strong
FY 2025 Total $3,264,907 26.3% 21.0% โ€”
02b

Visual Trends โ€” FY 2025

Monthly Revenue

12-month trend ยท FY 2025

IBDS Margin
Data Coverage: 6 of 12 months

Income Before Doctor Sharing ยท where known

Final Operating Margin
Data Coverage: 5 of 12 months

Income From Operations ยท where known

Cost Watch โ€” Key Categories

Business Assistants ยท Lab+Invisalign ยท CC Fees ยท % of revenue

Biz Asst Lab+Inv CC Fees

Data shown where available. Missing months reflect incomplete data capture. Dashed lines indicate estimated continuation between known points.

03

Monthly Analysis

CPA-style interpretation of each month. Click any row to expand.

January 2025 $286,768
Watch โ€บ
Total Revenue
$286,768
IBDS
$58,984
20.6% margin
Clinical Labor
Doctor 21.7% $62,156
Hygiene 9.8% $28,160
Assistants 5.3% $15,206
Admin Labor
Business Asst. 8.7% $24,966
Clinical Costs
Supplies 3.7% $10,657
Invisalign Lab 4.3% $12,267
Lab Fees 1.6% $4,706
Fixed Costs
Occupancy 3.4% $9,769
Admin
Credit Card Fees 2.5% $7,108
Software 1.6% $4,637
Distortion
Payroll Taxes 5.4% $15,467
Q1 reset โ€” not recurring at this level
Analysis

Cost-heavy opening month. Revenue was solid but expense load โ€” driven by Q1 payroll tax resets, elevated hygiene, and above-baseline supplies โ€” compressed margins from the start.

Payroll taxes and Invisalign are the primary distortion items. The recurring cost structure is acceptable; normalization in Q2 was expected and occurred.

February 2025 $275,012
Watch โ€บ
Total Revenue
$275,012
IBDS
21.9%
Adjusted margin (excl. travel) significantly higher
Clinical Labor
Doctor 21.3% $58,578
Hygiene 8.7% $23,926
Assistants 5.3% $14,576
Admin Labor
Business Asst. 9.4% $25,851
Clinical Costs
Supplies 1.5% $4,125
Invisalign Lab 2.5% $6,875
Lab Fees 1.3% $3,575
Admin Costs
Credit Card Fees 2.2% $6,050
Distortion
Travel & Meetings 6.6% $18,151
One-time spike โ€” not a recurring expense
Analysis

Revenue softened slightly from January. The reported 21.9% IBDS margin is understated โ€” a travel and meetings spike of 6.6% distorted the picture materially.

Excluding the travel item, the normalized recurring cost structure is acceptable. Supplies improved meaningfully vs. January. The recurring operating baseline is stronger than reported margin suggests.

March 2025 $305,156
Strong โ€บ
Interpretation

Major improvement month. Revenue stepped up and expense categories largely normalized, producing a clean 30.9% margin across both IBDS and final ops.

Where the money went
  • Payroll taxes normalized post-Q1
  • Travel normalized โ€” no spike
  • Cleaner overall expense mix
Verdict

This is the practice operating closer to its natural efficiency level. A useful baseline for what controlled months look like.

April 2025 $332,794
Elite โ€บ
Interpretation

Benchmark month for this practice. Strong production, controlled costs across every major category. IBDS reached 33.2% โ€” the clearest look at what this model is capable of.

Where the money went
  • Labor well-controlled
  • Marketing minimal
  • Occupancy efficient
Verdict

Elite. April is the performance ceiling reference point โ€” use it as the target model for scheduling and cost management.

May 2025 $214,397
Weak โ€บ
Interpretation

Revenue compression month โ€” the lowest of the year. Fixed and semi-fixed costs did not scale down proportionally, exposing the structural cost floor when production drops.

Where the money went
  • Front office and hygiene ratios high relative to revenue
  • Staffing stayed heavy despite lower production
  • Fixed costs fully exposed
Verdict

Inefficient. Revenue shortfall drove this โ€” not a cost spiral. Priority is maintaining production volume above the fixed cost floor.

June 2025 $269,628
Strong โ€บ
Interpretation

Solid recovery from May. Revenue returned to a workable level and labor normalized. Expense discipline held across most categories.

Where the money went
  • Labor normalized โ€” good ratio to revenue
  • Overall cost control decent
  • Invisalign still a watch item
Verdict

Efficient recovery month. The model re-stabilized quickly after May's compression.

July 2025 $359,708
Elite โ€บ
Interpretation

Highest revenue month of the year. Operationally strong โ€” production absorbed the higher variable costs comfortably. IBDS margin reached 31.3%. Final ops margin was distorted by doctor sharing timing.

Where the money went
  • Invisalign and lab costs elevated โ€” absorbed by production
  • Doctor sharing distorted final ops line
  • Otherwise clean expense structure
Verdict

Elite operationally. Use IBDS as the accurate performance read โ€” final ops understates true operational quality this month.

August 2025 $248,656
Watch โ€บ
Interpretation

Revenue pulled back from July's peak, and the fixed cost base felt proportionally heavier. A common pattern when a high-production month is followed by a softer one.

Where the money went
  • Admin and fixed costs felt heavier at lower revenue
  • Credit card fees jumped โ€” likely higher-ticket payment mix
Verdict

Watch. Nothing structurally broken โ€” revenue needs to stay above $240K to maintain acceptable margins on this cost base.

September 2025 $230,993
Weak โ€บ
Interpretation

Multiple cost categories ran elevated simultaneously while revenue stayed soft. The combination of lower production and higher-than-normal costs across the board made this the least efficient month of the year.

Where the money went
  • Hygiene payroll elevated
  • Assistant payroll elevated
  • Front office running heavy
  • Supplies above baseline
Verdict

Inefficient. A convergence of multiple elevated categories โ€” not a single driver. Warrants review of scheduling and staffing ratios.

October 2025 $243,742
Strong โ€บ
Interpretation

Stabilization month. Revenue held at a workable level and the expense base tightened back up after September's drift. A clean, controlled month.

Where the money went
  • Labor improved โ€” better ratio to revenue
  • Supplies normalized
  • Cleaner overall than the prior two months
Verdict

Efficient. The practice self-corrected after September โ€” a positive signal for operational resilience.

November 2025 $238,601
Watch โ€บ
Interpretation

Softer revenue month with some payroll line items running above ideal. Invisalign being low helped offset, preventing a worse outcome.

Where the money went
  • Assistant payroll elevated
  • Front office payroll running somewhat heavy
  • Invisalign low โ€” partially offset the labor drag
Verdict

Watch. Typical pre-holiday softness in revenue. Nothing structurally concerning, but payroll ratios should be monitored if revenue stays soft.

December 2025 $259,452
Strong โ€บ
Interpretation

Solid close to the fiscal year. Revenue improved from November and expenses were reasonably controlled. Assistants normalized. A 24.5% margin is a healthy finish.

Where the money went
  • Assistants normalized โ€” a positive shift from November
  • Front office still somewhat heavy
  • Overall expense mix manageable
Verdict

Efficient. A good year-end result. Front office payroll is the one line item to watch heading into 2026.

04

Cost Structure

Category-level analysis of the 2025 expense base. Each line item is assessed by pattern, behavior, and operational classification.

Strength Neutral Watch
Labor
Doctor Payroll
Strength
The largest single line item and the most predictable. Doctor compensation as a share of revenue held generally disciplined in the low-20% range throughout 2025.
2025 Pattern Consistent. No material spikes or anomalies outside of months where doctor sharing timing distorted the final ops line. IBDS removes this variable cleanly.
Hygiene Payroll
Watch
Reasonably controlled in strong-revenue months, but the cost base shows rigidity โ€” it does not compress proportionally when production is lower.
2025 Pattern Ran heavier in lower-revenue months (May, September). Semi-fixed in nature. Monitor the hygiene-to-revenue ratio closely; it is the clearest indicator of scheduling efficiency.
Dental Assistants
Strength
Generally efficient relative to production. Assistant payroll was well-managed in most months and did not emerge as a consistent pressure point during 2025.
2025 Pattern Normalized in most months. Ran slightly heavy in November but corrected in December. No structural concern โ€” this is a managed line item.
Business Assistants (Front Office)
Major Watch
The most persistent cost pressure point in the practice. Front office payroll repeatedly ran in the 9โ€“11% range โ€” above where it should sit relative to this revenue base.
2025 Pattern Heavy in September, November, and December. Present as a background drag in most other months. This is the single highest-priority labor line item for review heading into 2026.
Clinical & Variable
Supplies
Major Strength
One of the most notable cost advantages in this practice. Supply costs ran well below typical dental benchmarks throughout the year โ€” a meaningful structural advantage.
2025 Pattern Consistently low. Industry average sits at 5โ€“7%; this practice consistently operated well below that threshold. Elevated briefly in January and September, but not meaningfully.
Lab + Invisalign
Watch
A volatile, case-mix-sensitive category. Not inherently problematic โ€” higher lab costs often accompany higher-value production โ€” but the variability warrants monitoring.
2025 Pattern Elevated in January, July, and at various points across the year. Invisalign component was specifically low in November, which partially offset other pressures that month. Best managed at the case level.
Overhead & Fixed
Occupancy
Strength
Rent and facility costs are reasonable and well-controlled. Occupancy as a percentage of revenue is below industry norms, reflecting either favorable lease terms or efficient use of space.
2025 Pattern Stable throughout the year. No spikes or anomalies. The fixed nature of this cost means it improves automatically as production increases.
Marketing
Strength
Minimal external marketing spend. The practice generates patient volume primarily through referrals and retention rather than paid acquisition โ€” a structurally efficient model.
2025 Pattern Low and consistent. No material spend throughout the year. If growth becomes a priority, this line item has room to absorb investment without disrupting the overall cost structure.
Credit Card Fees
Watch
An inconsistent line item with clear optimization potential. Processing fees spiked in certain months, suggesting an unmanaged payment mix. This is a recoverable cost with the right collection strategy.
2025 Pattern Elevated in February and August. Inconsistent month-to-month. Shifting a portion of collections toward ACH, check, or cash-pay discounts would meaningfully reduce this expense with minimal patient friction.
Travel & Meetings
Non-Core
A non-recurring distortion item. The spike observed in February 2025 was material enough to compress that month's reported margin and should be excluded when evaluating the normalized operating baseline.
2025 Pattern Concentrated in February. Minimal presence in other months. For analytical purposes, February's reported margin should be normalized to remove this distortion before drawing conclusions about run-rate performance.
06

Key Strengths

Structural advantages that define the operating model and support above-average performance.

โ—†
Revenue Base
Annual revenue of approximately $3.26M from a single-doctor, four-day-per-week model is materially above typical single-location benchmarks. The revenue base provides sufficient operating leverage across the fixed cost structure.
โ—†
IBDS Margin
Income Before Doctor Sharing averaged approximately 26% for the year. This margin โ€” before any owner compensation allocation โ€” reflects genuine practice-level profitability and a well-controlled cost structure.
โ—†
Production Density
Revenue per doctor day of approximately $15,700 significantly exceeds industry averages of $8,000โ€“$12,000. This density is the primary engine of the practice's financial performance and reflects strong case mix and scheduling utilization.
โ—†
Supply Cost Control
Supply costs ran well below the industry benchmark of 5โ€“7% throughout 2025. This is one of the most defensible cost advantages in the practice โ€” it reflects procurement discipline that does not require ongoing active management to sustain.
โ—†
Low Marketing Dependence
Marketing spend remained minimal relative to revenue throughout the year. Patient acquisition appears to be driven primarily by referral and retention โ€” a structurally efficient model that does not require paid channels to sustain volume.
โ—†
Controlled Occupancy
Facility and rent costs held well below the 6โ€“8% industry average throughout the year. This fixed cost advantage compounds as revenue grows โ€” the same space supports materially higher production without a corresponding increase in occupancy expense.
โ—†
Elite Ceiling Performance
April and July 2025 demonstrated the practice's performance ceiling โ€” IBDS margins above 31โ€“33% on strong production months. These months confirm that the model is structurally capable of sustained high-margin performance when revenue and costs align. The goal is narrowing the gap between ceiling and floor performance, not raising the ceiling further.
07

Risks & Watch Items

Observed patterns that introduce margin pressure, reporting distortion, or structural vulnerability if left unaddressed.

Primary
Front Office Payroll Creep
Business assistant costs repeatedly ran in the 9โ€“11% range โ€” above the 8โ€“8.5% target for a practice at this revenue level. This is the single most persistent cost pressure point identified in 2025. It does not create acute margin risk in strong months, but it compresses margins meaningfully in softer months and limits the practice's ability to absorb revenue variability.
Monitor
Lab & Invisalign Variability
Lab and Invisalign costs are case-mix sensitive by nature, but the degree of monthly variability observed in 2025 warrants attention. In high-production months, elevated lab costs are absorbed easily. In softer months, they compound margin pressure. Case-level margin review and lab pricing discipline should be ongoing practices, not reactive ones.
Monitor
Revenue Volatility
Monthly revenue ranged from approximately $214K (May) to $360K (July) โ€” a spread of over $145K. While a single-doctor practice inherently carries scheduling variability, the magnitude of this range creates real operating risk: the cost structure does not contract proportionally in lower-revenue months, meaning margin compression in soft months is sharper than the revenue decline alone would suggest.
Addressable
Credit Card Fee Inconsistency
Processing fees spiked in February and August without a corresponding increase in production volume. This suggests the payment mix is unmanaged rather than strategically set. This is a recoverable cost item โ€” migrating a portion of collections to ACH or check would reduce this expense with minimal disruption to patient experience.
Normalize
Travel & Meetings Distortion
The February 2025 travel and meetings spike was material enough to compress the reported final margin for that month. This cost does not reflect normal operating activity. Any period-over-period analysis of February should normalize for this item before drawing conclusions about operating trend.
Monitor
Fixed Cost Exposure in Soft Months
The practice carries a meaningful semi-fixed cost base โ€” hygiene payroll, front office staffing, and occupancy do not compress proportionally when production declines. This creates an asymmetric margin profile: strong months outperform their revenue advantage, and weak months underperform. Managing revenue consistency is the most effective lever for mitigating this structural exposure.
08

Improvement Roadmap

Prioritized operational actions to improve margin consistency, reduce cost drag, and increase performance floor.

01
Reduce Business Assistant Cost to 8.5โ€“9.0%
Front office payroll is the highest-priority cost reduction opportunity. Bringing the business assistant ratio from the current 9โ€“11% range to 8.5โ€“9.0% on a sustained basis would recover an estimated $20Kโ€“$40K annually in operating income. This should be addressed through scheduling optimization and headcount review, not through service reduction.
Priority 1 Est. impact: $20Kโ€“$40K/yr
02
Optimize Payment Mix to Reduce Credit Card Fee Drag
Implement a structured payment collection policy that actively directs patients toward ACH, check, or in-office financing options. A modest shift in payment mix โ€” moving 25โ€“30% of volume off card โ€” would meaningfully reduce this expense line without requiring any clinical or operational changes.
Priority 2 Est. impact: $5Kโ€“$10K/yr
03
Monitor Lab Pricing and Case Mix Margins
Establish a quarterly review of lab invoices against production to identify cases where lab cost is disproportionate to fee collected. Renegotiate vendor terms if volume supports it. Evaluate Invisalign case profitability independently from general lab costs โ€” the two have different margin profiles and should be tracked separately.
Priority 2 Est. impact: $8Kโ€“$15K/yr
04
Implement Monthly Variance Review Discipline
Introduce a monthly close review that compares actual results against prior month and a normalized baseline. The goal is early identification of category drift before it becomes a structural pattern. Business assistant costs, lab/Invisalign, and credit card fees are the three lines that warrant month-to-month attention. This is a process discipline, not a systems investment.
Operational Protects existing margin
05
Reduce Low-Month Volatility Through Scheduling and Recall Consistency
The gap between the practice's floor and ceiling performance months is wider than the cost structure can efficiently absorb. Tightening recall systems, reducing scheduling gaps, and building a consistent production target for lower-volume months would raise the revenue floor โ€” which in turn narrows the margin range and reduces fixed cost exposure. Even a $20K increase in the average soft month would have meaningful margin impact given the practice's cost structure.
Operational Est. impact: $30Kโ€“$60K/yr

A high-efficiency model with
strong unit economics.

At $3.26M annual revenue, 21% final operating margin, and $15,700 per doctor day, Family Dental Care of Owasso operates well above single-doctor practice benchmarks. The cost structure is lean, the production density is elite, and the model is structurally scalable.

High Efficiency Strong Margins Lean Overhead Scalable Model Organic Growth Elite Production